Literature DB >> 14757779

Overlap between whites and blacks in response to antihypertensive drugs.

Ashwini R Sehgal1.   

Abstract

On average, whites and blacks differ in their response to specific antihypertensive drugs. These differences are often highlighted in reviews and practice guidelines. However, there is wide variation in drug-associated changes in blood pressure within each race. The goal of this meta-analysis is to quantitate how often whites and blacks have similar responses to specific antihypertensive drugs. Computerized searches of MEDLINE (1983 to March 2003) and manual searches of references listed in identified articles were performed. Studies were included if they provided race-specific changes in blood pressure. Fifteen studies with a total of 9307 white subjects and 2902 black subjects were analyzed. For drug-associated changes in diastolic blood pressure, the mean difference between whites and blacks ranged from 0.6 to 3.0 mm Hg while the standard deviation within each race ranged from 5.0 to 10.1 mm Hg. The percentage of whites and blacks with similar drug-associated changes in diastolic blood pressure was 90% (95% confidence interval: 81 to 99) for diuretics, 90% (95% CI: 83 to 97) for beta-blockers, 95% (95% CI: 92 to 98) for calcium channel blockers, and 81% (95% CI: 76 to 86) for angiotensin converting enzyme inhibitors. The percentage of whites and blacks with similar drug-associated changes in systolic blood pressure ranged from 83% to 93%. In conclusion, the majority of whites and blacks have similar responses to commonly used antihypertensive drugs. Clinical decisions to use a specific drug should be based on other considerations such as efficacy in individual patients, compelling indications, and cost.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14757779     DOI: 10.1161/01.HYP.0000118019.28487.9c

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  26 in total

1.  The RICH LIFE Project: A cluster randomized pragmatic trial comparing the effectiveness of health system only vs. health system Plus a collaborative/stepped care intervention to reduce hypertension disparities.

Authors:  Lisa A Cooper; Jill A Marsteller; Kathryn A Carson; Katherine B Dietz; Romsai T Boonyasai; Carmen Alvarez; Chidinma A Ibe; Deidra C Crews; Hsin-Chieh Yeh; Edgar R Miller; Cheryl R Dennison-Himmelfarb; Lisa H Lubomski; Tanjala S Purnell; Felicia Hill-Briggs; Nae-Yuh Wang
Journal:  Am Heart J       Date:  2020-05-08       Impact factor: 4.749

Review 2.  Personalized vascular medicine: individualizing drug therapy.

Authors:  Emil M Degoma; Giovanni Rivera; Scott M Lilly; M Haris U Usman; Emile R Mohler
Journal:  Vasc Med       Date:  2011-10       Impact factor: 3.239

3.  Hypertension and ethnic group.

Authors:  Morris J Brown
Journal:  BMJ       Date:  2006-04-08

4.  Cumulative burden of atherosclerotic risk genotypes and the age at onset of a first myocardial infarction: a case-only carriership approach.

Authors:  Ilan Goldenberg; Arthur J Moss; Daniel Ryan; Grzegorz Pietrasik; Wojciech Zareba; Scott McNitt; Shirley W Eberly
Journal:  Ann Noninvasive Electrocardiol       Date:  2008-07       Impact factor: 1.468

Review 5.  Hypertension in African Americans.

Authors:  Nomsa Musemwa; Crystal A Gadegbeku
Journal:  Curr Cardiol Rep       Date:  2017-10-28       Impact factor: 2.931

Review 6.  Ethnic differences in cardiovascular drug response: potential contribution of pharmacogenetics.

Authors:  Julie A Johnson
Journal:  Circulation       Date:  2008-09-23       Impact factor: 29.690

7.  Does race have a place in biotechnological research?

Authors:  Jack McCain
Journal:  Biotechnol Healthc       Date:  2005-12

8.  Reducing racial and ethnic disparities in hypertension prevention and control: what will it take to translate research into practice and policy?

Authors:  Michael Mueller; Tanjala S Purnell; George A Mensah; Lisa A Cooper
Journal:  Am J Hypertens       Date:  2014-12-12       Impact factor: 2.689

Review 9.  Racial differences in blood pressure response to calcium channel blocker monotherapy: a meta-analysis.

Authors:  Thu T Nguyen; Jay S Kaufman; Eric A Whitsel; Richard S Cooper
Journal:  Am J Hypertens       Date:  2009-06-04       Impact factor: 2.689

10.  Influence of patient race on physician prescribing decisions: a randomized on-line experiment.

Authors:  Saif S Rathore; Jonathan D Ketcham; G Caleb Alexander; Andrew J Epstein
Journal:  J Gen Intern Med       Date:  2009-08-25       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.